Cover Image

Current treatment and novel insights regarding ROS1‐targeted therapy in malignant tumors

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Shizhe Li, He Zhang, Ting Chen, Xiaowen Zhang, Guanning Shang
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	Cancer Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Phase I study of BC001, a novel fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor‐2, in advanced solid tumors
by: Dan Liu, et al.
Published: (2024)

Incidence, clinical features, and survival outcomes of primary malignant lacrimal gland tumors: A population‐based analysis
by: Lin‐feng He, et al.
Published: (2024)

Biomarkers of peripheral blood neutrophil extracellular traps in the diagnosis and progression of malignant tumors
by: Min Wang, et al.
Published: (2024)

Impact of different respiratory gating methods on target delineation and a radiotherapy plan for solitary pulmonary tumors
by: Dongping Shang, et al.
Published: (2024)

DEPDC1B: A novel tumor suppressor gene associated with immune infiltration in colon adenocarcinoma
by: Dandan Zhu, et al.
Published: (2024)

Association between gut microbiota and malignant cardiac tumors: A two‐sample Mendelian randomization study
by: Yongfei Song, et al.
Published: (2024)

Predictive factors for peripheral blood stem cell mobilization in multiple myeloma in the era of novel therapies: A single‐center experience
by: Xiao He, et al.
Published: (2024)

New clinical insights into the treatment of benign uretero‐ileal anastomotic stricture following radical cystectomy and urinary diversion
by: Yixuan Mou, et al.
Published: (2024)

Indicators describing the tumor lesion aggregation and dissemination and their impact on the prognosis of patients with diffuse large B cell lymphoma receiving chimeric antigen receptor T cell therapy
by: Xiuyong Dang, et al.
Published: (2024)

Chidamide plus envafolimab as subsequent treatment in advanced non‐small cell lung cancer patients resistant to anti‐PD‐1 therapy: A multicohort, open‐label, phase II trial with biomarker analysis
by: Yaxiong Zhang, et al.
Published: (2024)

The role of programmed cell death in osteosarcoma: From pathogenesis to therapy
by: Suqing Liu, et al.
Published: (2024)

A retrospective study of first‐line therapy and subsequent pyrotinib treatment in advanced lung adenocarcinoma with HER2 mutations
by: Li Wang, et al.
Published: (2024)

Obesity enhances the response to neoadjuvant anti‐ PD1 therapy in oral tongue squamous cell carcinoma
by: Xiyan Tan, et al.
Published: (2024)

PD ‐1 blockade enhances the effect of targeted chemotherapy on locally advanced pMMR / MSS colorectal cancer
by: Fengyun Pei, et al.
Published: (2024)

Inosine enhances the efficacy of immune‐checkpoint inhibitors in advanced solid tumors: A randomized, controlled, Phase 2 study
by: Haiqing Zhao, et al.
Published: (2024)

Comparison of IL‐2‐antibody to IL‐2‐Fc with or without stereotactic radiation therapy in CEA immunocompetent mice with CEA positive tumors
by: Lindsay Williams, et al.
Published: (2024)

Mitochondrial dynamics as a novel treatment strategy for triple‐negative breast cancer
by: Yuechen Wang, et al.
Published: (2024)

Real‐world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B‐cell lymphoma by line of therapy
by: Helmneh M. Sineshaw, et al.
Published: (2024)

Clinical Progression Modes of Crizotinib Failure and Subsequent Management of Advanced Non‐Small Cell Lung Cancer With ROS 1 Rearrangement
by: Quan‐Quan Tan, et al.
Published: (2026)

Identification of molecular characteristics of hepatocellular carcinoma with microvascular invasion based on deep targeted sequencing
by: Linlin Zheng, et al.
Published: (2024)

Racial differences in treatment adherence and response to acupuncture and cognitive behavioral therapy for insomnia among Black and White cancer survivors
by: Kevin T. Liou, et al.
Published: (2024)

Do corticosteroids affect immunotherapy efficacy in malignancy? – A systematic review
by: Yoni Byron, et al.
Published: (2024)

Survival outcome and predictors of WHO grade 2 and 3 insular gliomas: A classification based on the tumor spread
by: Bowen Xue, et al.
Published: (2024)

ROS1 Expression Correlates With Inguinal Lymph Node Affection in Vulvar Cancer Patients: A Retrospective Study
by: Meletios P. Nigdelis, et al.
Published: (2025)

Combination tumor‐treating fields treatment for patients with metastatic non‐small cell lung cancer: A cost‐effectiveness analysis
by: Kun Liu, et al.
Published: (2024)

Meta‐analysis on axillary lymph node metastasis rate in ductal carcinoma in situ with microinvasion
by: Xiongxiong Li, et al.
Published: (2024)

Analytical and clinical validation of a NGS panel in detecting targetable variants from ctDNA of metastatic NSCLC patients
by: Feifei Fan, et al.
Published: (2024)

Metabolite signature of human malignant thyroid tissue: A systematic review and meta‐analysis
by: S. Adeleh Razavi, et al.
Published: (2024)

Impact of rural location on receipt of standard of care treatment and survival for locally advanced bladder cancer in Louisiana
by: Megan Escott, et al.
Published: (2024)

Real‐world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer
by: Jasmine S. Sukumar, et al.
Published: (2024)

Progression in low‐intensity ultrasound‐induced tumor radiosensitization
by: Haonan Xu, et al.
Published: (2024)

Immunotherapy in Thyroid Cancer: Current Strategies and Challenges
by: Qian Zhang, et al.
Published: (2026)

Impact of measurable residual disease in combination with CD19 on postremission therapy choices for adult t(8;21) acute myeloid leukemia in first complete remission
by: Xi Jia, et al.
Published: (2024)

RBBP4: A novel diagnostic and prognostic biomarker for non‐small‐cell lung cancer correlated with autophagic cell death
by: Yajing Zhan, et al.
Published: (2024)

Correction to “Indicators describing the tumor lesion aggregation and dissemination and their impact on the prognosis of patients with diffuse large B cell lymphoma receiving chimeric antigen receptor T cell therapy”
Published: (2025)

Heterogeneity‐induced NGF‐NGFR communication inefficiency promotes mitotic spindle disorganization in exhausted T cells through PREX1 suppression to impair the anti‐tumor immunotherapy with PD‐1 mAb in hepatocellular carcinoma
by: Xin Wang, et al.
Published: (2024)

α‐Hederin induces paraptosis by targeting GPCRs to activate Ca2+/MAPK signaling pathway in colorectal cancer
by: Xiwu Rao, et al.
Published: (2024)

Extracellular glypican‐1 affects tumor progression and prognosis in esophageal cancer
by: Rie Shibata, et al.
Published: (2024)

Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms
by: Kelly S. Chien, et al.
Published: (2024)

Activin A promoted the anti‐tumor effect of ActRIIA high CD8 + T cells in mouse hepatoma
by: Liangchang Hu, et al.
Published: (2024)